Journal of the Neurological Sciences
Volume 316, Issue 1 , Pages 189-190 , 15 May 2012

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

  • A.J. Larner

      Affiliations

    • Corresponding Author InformationWalton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerley, Liverpool, L9 7LJ, United Kingdom. Fax: +44 151 529 8552.

Received 23 September 2011 ,Revised 23 December 2011 ,Accepted 4 January 2012.

References 

  1. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–919
  2. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920–924
  3. Alzheimer Disease and Frontotemporal Dementia Mutation Database . http://www.molgen.ua.ac.be/Admutations(accessed 01/12/11).
  4. Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71:1220–1226
  5. Rohrer JD, Guerriero R, Vandrovcova J, Uphill J, Reiman D, Beck J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451–1456
  6. Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131:706–720
  7. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AM, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131:721–731
  8. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, et al. Phenotype variability in progranulin mutation carriers; a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131:732–746
  9. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C>T (Arg493X) mutation: an international initiative. Lancet Neurol. 2007;6:857–868
  10. Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65:1817–1819
  11. Rohrer JD, Ridgway GR, Modat M, Ourselin S, Mead S, Fox NC, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage. 2010;53:1070–1076
  12. Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype?. Neuropsychologia. 2010;48:288–297
  13. Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology. 2010;74:42–49
  14. Larner AJ, Doran M. Clinical heterogeneity associated with tau gene mutations. Eur Neurol Rev. 2009;3(2):31–32
  15. Larner AJ. Intrafamilial clinical phenotypic heterogeneity with MAPT gene splice site IVS10+16C>T mutation. J Neurol Sci. 2009;287:253–256
  16. Goldman JS, Rademakers R, Huey ED, Boxer AL, Mayeux R, Miller BL, et al. An algorithm for genetic testing of frontotemporal lobar degeneration. Neurology. 2011;76:475–483

PII: S0022-510X(12)00006-8

doi: 10.1016/j.jns.2012.01.005

Journal of the Neurological Sciences
Volume 316, Issue 1 , Pages 189-190 , 15 May 2012

Article Tools